TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | 5 | 4 | -6 | 26 | -40 | -1 |
| P | %wins | 67 | 100 | 67 | 33 | 67 | 0 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/10 16:36 | 9/23/10 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Steven W | CA | DO | P,CEO | P.d | 7 | 1.33 | 0 | 5 | 6 | 93 | D | -19 | -62 | -57 | -51 | -11 | -9 | -5 | -6 | 6 | 6 | 13 | 40 | 79 | -19 |
8/31/07 18:43 | 8/31/07 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Steven W | CA | DO | P,CEO | P.d | 4 | 0.7330 | 0 | 5 | 6 | 92 | D | -40 | -51 | -32 | -41 | -11 | 1 | 11 | 0 | -1 | 0 | -12 | -37 | -10 | -62 |
8/20/07 21:47 | 8/20/07 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Steven W | CA | DO | P,CEO | P.d | 10 | 0.5888 | 0 | 17 | 24 | 87 | D | -44 | -52 | -44 | -33 | -22 | -14 | -9 | 5 | 1 | 9 | 12 | -22 | 9 | -38 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |